Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats - PubMed (original) (raw)
Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats
L Fattore et al. Psychopharmacology (Berl). 2001 Aug.
Abstract
Rationale: Delta9-tetrahydrocannabinol (Delta9-THC), the main psychoactive ingredient of marijuana, as well as synthetic cannabinoid (CB1) receptor agonists, has led to negative or equivocal results when tested with the intravenous self-administration procedure, the best validated behavioural model for evaluating abuse liability of drugs in experimental animals. We recently reported, however, that the synthetic CB1 receptor agonist WIN 55,212-2 is intravenously self-administered by drug-naive mice and that its self-administration is blocked by the cannabinoid CB1 receptor antagonist SR 141716A.
Objective: To assess a reliable model of cannabinoid intravenous self-administration in rats. Long Evans male rats were allowed the opportunity to self-administer WIN 55,212-2 at doses ranging from 6.25 to 50 microg/kg per injection, under a fixed-ratio 1 (FR1) schedule of reinforcement and nose-pokes as the operant responses. The effect of either a change in the unit drug dose available or a pretreatment with the specific CB1 receptor antagonist SR 141716A were then investigated (maintenance phase). Finally, the extinction of the self-administration behaviour was evaluated.
Results: Response rate depended on the drug dose available, with maximum rates occurring at 12.5 microg/kg per injection. Response rate increased following pretreatment with the specific CB1 receptor antagonist, SR 141716A. Moreover, operant behaviour rapidly extinguished following both the substitution of saline or vehicle for cannabinoid and the disconnection of the drug delivery pumps.
Conclusion: Rats will intravenously self-administer the synthetic CB1 receptor agonist WIN 55,212-2 under specific experimental conditions, thus allowing further investigation of the neurobiological mechanisms underlying cannabinoid-taking behaviour.
Similar articles
- Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
McMahon LR. McMahon LR. Psychopharmacology (Berl). 2006 Oct;188(3):306-14. doi: 10.1007/s00213-006-0500-6. Epub 2006 Sep 5. Psychopharmacology (Berl). 2006. PMID: 16953389 - CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats.
Fattore L, Martellotta MC, Cossu G, Mascia MS, Fratta W. Fattore L, et al. Behav Brain Res. 1999 Oct;104(1-2):141-6. doi: 10.1016/s0166-4328(99)00059-5. Behav Brain Res. 1999. PMID: 11125733 - CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat.
Spano MS, Fattore L, Cossu G, Deiana S, Fadda P, Fratta W. Spano MS, et al. Br J Pharmacol. 2004 Oct;143(3):343-50. doi: 10.1038/sj.bjp.0705932. Epub 2004 Aug 31. Br J Pharmacol. 2004. PMID: 15339858 Free PMC article. - Cannabinoids, hippocampal function and memory.
Hampson RE, Deadwyler SA. Hampson RE, et al. Life Sci. 1999;65(6-7):715-23. doi: 10.1016/s0024-3205(99)00294-5. Life Sci. 1999. PMID: 10462072 Review. - [Drug discrimination properties and cytotoxicity of the cannabinoid receptor ligands].
Tomiyama K, Funada M. Tomiyama K, et al. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2012 Jun;47(3):135-43. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2012. PMID: 22894054 Review. Japanese.
Cited by
- Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats.
Scherma M, Fattore L, Satta V, Businco F, Pigliacampo B, Goldberg SR, Dessi C, Fratta W, Fadda P. Scherma M, et al. Br J Pharmacol. 2013 Jun;169(4):820-33. doi: 10.1111/bph.12014. Br J Pharmacol. 2013. PMID: 23072421 Free PMC article. - Screening Medications for the Treatment of Cannabis Use Disorder.
Panlilio LV, Justinova Z, Trigo JM, Le Foll B. Panlilio LV, et al. Int Rev Neurobiol. 2016;126:87-120. doi: 10.1016/bs.irn.2016.02.005. Epub 2016 Mar 10. Int Rev Neurobiol. 2016. PMID: 27055612 Free PMC article. Review. - Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats.
Scherma M, Dessì C, Muntoni AL, Lecca S, Satta V, Luchicchi A, Pistis M, Panlilio LV, Fattore L, Goldberg SR, Fratta W, Fadda P. Scherma M, et al. Neuropsychopharmacology. 2016 Apr;41(5):1416-26. doi: 10.1038/npp.2015.295. Epub 2015 Sep 21. Neuropsychopharmacology. 2016. PMID: 26388146 Free PMC article. - Behavioral Determinants of Cannabinoid Self-Administration in Old World Monkeys.
John WS, Martin TJ, Nader MA. John WS, et al. Neuropsychopharmacology. 2017 Jun;42(7):1522-1530. doi: 10.1038/npp.2017.2. Epub 2017 Jan 6. Neuropsychopharmacology. 2017. PMID: 28059083 Free PMC article. - Self-Administration of an Endogenous Cannabinoid 2-Arachidonoylglycerol in Experimentally Naïve Rats.
Hiranita T. Hiranita T. J Alcohol Drug Depend. 2015 Oct;3(5):e126. doi: 10.4172/2329-6488.1000e126. Epub 2015 Oct 17. J Alcohol Drug Depend. 2015. PMID: 27376099 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous